Article Text

PDF
Review: azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn’s disease

Statistics from Altmetric.com

A K Akobeng

Dr A K Akobeng, Booth Hall Children’s Hospital, Manchester, UK; tony.akobeng@cmmc.nhs.uk

QUESTION

Which interventions are effective for maintaining remission in Crohn’s disease?

REVIEW SCOPE

Included studies evaluated interventions for maintaining remission in Crohn’s disease. Outcome was maintenance of remission (or relapse).

REVIEW METHODS

Medline (1966 to May 2007), Cochrane Library (Issue 2, 2007), and Cochrane Inflammatory Bowel Disease Group were searched for randomised controlled trials (RCTs) or systematic reviews or meta-analyses of RCTs. 8 interventions (azathioprine, 5-aminosalicylates, corticosteroids, budesonide, antimycobacterial agents, probiotics, omega-3 fatty acids, and enteral nutrition) were evaluated in systematic reviews, and 6 interventions (methotrexate, infliximab, adalimumab, natalizumab, certolizumab, and ciclosporin) were evaluated in RCTs. …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.